Circulating tumor DNA predicts breast cancer relapse after treatment
DNA
European Organisation for Research and Treatment of Cancer Mar 26 2026 Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery. The study, presented at the 15 th European Breast Cancer Conference (EBCC15) in Barcelona today (Friday), included the largest number of events reported so far for circulating tumor DNA (ctDNA) in
din zilele anterioare